BeStock  
股票 › 生物科技 › MRNA

莫德纳 MRNA

$254.19 +$12.73 (+5.27%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $256.92 +1.07%
开盘$245.40
昨收$241.46
当日区间$237.86 – $267.50
成交量16.33M
市值$101.48B
市盈率(TTM)–
股息率–

MRNA 相关新闻

匹配 Moderna 或代码 MRNA 的头条新闻,按最新排序。

  • Beta Pharma (300558.SZ): Currently has no relevant layout in the mRNA field.Gelonghui Finance · 9 Sep 2026 · 直接提及
  • HK Stock Market Alert | Jitai Technology-P (07666) surges over 20% in afternoon session; cumulative gain exceeds 30% in two days of inclusion in the Stock Connect. Global AI + mRNA vaccine sector accelerates. 正面Zhitong Finance · 8 Sep 2026 · 直接提及
  • Hualan Biological Engineering Inc. (002007.SZ): Controlled subsidiary receives approval notice for clinical trials of novel influenza mRNA vaccine 正面Gelonghui Finance · 7 Sep 2026 · 直接提及
  • Form 144 | Moderna(MRNA.US) Officer Proposes to Sell 4.69 Million in Common StocksMarket news · 10 Sep 2026 · 直接提及
  • Nano Holdings: New research findings on mRNA therapeutics have been announced by the group led by Professor Akihisa Iitaka.JPX · 4 Sep 2026 · 直接提及
  • mRNA‑related stocks lead gains: CanSino Biologics tops the pack, while Moderna's mRNA neoantigen therapy is set to debut at the ESMO Congress. 正面Zhitong Finance · 30 Sep 2026 · 直接提及
  • Hong Kong Stock Market Movers | CSPC Pharma (01093) rises nearly 6% following consecutive announcements of R&D progress, including developments in mRNA cancer vaccines and recombinant protein vaccines. 正面Zhitong Finance · 30 Sep 2026 · 直接提及
  • CanSino Biologics: Currently developing mRNA-based prophylactic vaccines and therapeutic biologics, as well as related delivery systems.Latest · 30 Sep 2026 · 直接提及
  • CanSino Biologics: Currently developing mRNA-based preventive vaccines and therapeutic biologics, along with related delivery systems.Latest · 30 Sep 2026 · 直接提及
  • mRNA cancer vaccines enter the confirmatory validation window; the underlying index of the E Fund Hong Kong Stock Connect Innovative Drug ETF (159316) rose nearly 4% today.Latest · 30 Sep 2026 · 直接提及
  • Rothschild & Co Redburn Initiates Moderna(MRNA.US) With Sell Rating, Announces Target Price $81Market news · 3 Sep 2026 · 直接提及
  • J.P. Morgan Maintains Moderna(MRNA.US) With Sell RatingMarket news · 29 Sep 2026 · 直接提及
  • DBS Maintains Moderna(MRNA.US) With Hold Rating, Raises Target Price to $150 正面Market news · 12 Sep 2026 · 直接提及
  • Argus Research Upgrades Moderna(MRNA.US) to Buy Rating, Announces Target Price $180 正面Market news · 28 Aug 2026 · 直接提及
  • US Stock Market Update: Moderna (MRNA.US) Surges Over 10% After Multiple Wall Street Banks Raise Price Targets 正面Zhitong Finance · 25 Aug 2026 · 直接提及

讨论区

暂无评论——快来第一个聊聊 MRNA。

登录后参与讨论。

Scroll to Top